Delivery Order SPE2DB22D2007-SPE2DB24FJ4NX
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA). The award is a $1,360.17 delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued up to $999,999,999 through December 2025. The contract is for the delivery of Qsymia 7.5 mg-46 mg capsules, a prescription medication. This order does not have a set-aside designation. Amerisourcebergen, through its...
This federal contract award, valued at $1,887.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QSYMIA 7.5 MG-46 MG capsules, with a performance period extending through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award (SPE2DB20D3303 | SPE2DB24FZ6U6) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,419.00 firm-fixed-price delivery order is for the supply of Qsymia 3.75 mg-23 mg capsules. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4568448460 QSYMIA 3.75 MG-23 MG CAPSULE 30S, with a ceiling value of $1,976.80. The contract type is a delivery order under a firm fixed price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,478.55, is for the delivery of the pharmaceutical product QSYMIA 7.5MG-46MG 30S. It is a firm fixed-price Delivery Order with a completion date of July 12, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is a delivery order valued at $1,630.25, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of QSYMIA 3.75 MG-23 MG capsules in 30-count packages. The contract has a firm fixed price and an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of QSYMIA 15 MG-92 MG CAPSULE 30S, a medication, with a ceiling value of $2,588.20 and a performance period extending to June 2025. The contract is a delivery order and is priced on a firm fixed price basis. It is not set aside for any particular business category. AmerisourceBergen Drug Corp...
This is a $3,656.97 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of the drug QSYMIA 3.75 MG-23 MG Capsule, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA Troop Support Medical to provide...